Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Glucocorticoid Action in Addison's Disease
NCT02152553Completed
- Sponsor
- Region Västra Götaland
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in Addison's disease comparing Hydrocortisone with Placebo (2 arms). Primary endpoints: Protein profile changes between a state of GC starvation and near physiological GC exposure at 24 hours and Metabolite profile changes between a state of GC starvation and near physiological GC exposure at 24 hours. Started May 2014; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on NCT02152553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152553.